Breaks Categories: News

MondayMar 16, 2020 9:43 am

NetworkNewsBreaks – Champignon Brands Inc. (CSE: SHRM) Enters Definitive Agreement to Acquire Craft Mushroom Cultivator Artisan Growers Ltd.

Champignon Brands (CSE: SHRM), a wellness company specializing in medicinal mushroom and mushroom-infused products, continues to advance its vertical integration through the addition of craft mushroom production, manufacturing and research capabilities. On Friday, the Company announced its entry into a definitive agreement to acquire Artisan Growers Ltd., a British Columbia based craft mushroom cultivator and supplier. Artisan Growers utilizes a variety of techniques and infrastructure to produce premium craft mushrooms, operating a craft cultivation facility capable of producing an assortment of organic varietals including Lion’s Mane, Chaga, Reishi and Agaricus Blazei. According to the update, Champignon plans to integrate Artisan…

Continue Reading

MondayMar 16, 2020 9:22 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) Receives Multiple Orders for New Hemp Seed Oil Infused Hand Sanitizer

SinglePoint (OTCQB: SING) recently launched Klen Hands, a moisturizing hand sanitizer with 62% ethyl alcohol to keep hands clean and hemp seed oil to keep hands soft and hydrated. Since the initial soft launch on Friday, March 13, 2020, the company has secured multiple orders for Klen and anticipates that to continue as the demand for cleaning and disinfect products continues to exceed current supply. “It is beneficial that we have a manufacturing facility already making other CBD/Hemp products and the relationships to quickly get supplies. This product is the right time and the right place. We are very happy…

Continue Reading

FridayMar 13, 2020 2:32 pm

NetworkNewsBreaks – SinglePoint, Inc. (SING) Launches Hand Sanitizer Infused with Hemp Seed Oil

SinglePoint (OTCQB: SING) today announced the launch of Klen Hands. Customers can subscribe and preorder now, and shipments are expected to leave the company’s Carlsbad facility in approximately 10 business days. There is a limited supply, which the company anticipates will sell out quickly. The hand sanitizer has 62% ethyl alcohol to keep hands “klen” (clean), as well as hemp seed oil to keep hands soft and hydrated. “We are working to develop solutions for both product and technology in order to assist in the effort of combating COVID-19. As many people know our company has deep ties to the…

Continue Reading

FridayMar 13, 2020 2:06 pm

NetworkNewsBreaks – Ideanomics, Inc. (NASDAQ: IDEX) Posts Update on Treeletrik Subsidiary

Ideanomics (NASDAQ: IDEX) recently provided an update on its Malaysia-based Treeletrik subsidiary’s expansion plans. In 2019 Ideanomics acquired 51% ownership in the holding companies of Treeletrik. Among other highlights, the company reported that the leasehold of land graded for development at the 250-acre site at Gebeng Industrial Estate in Kuantan, Pahang Darul Makmur, has been upgraded to title holder to offer Treeletrik flexibility with the development. The assessed value of the land is approximately 100 Million ringgit or $25 million. Treeletrik intends to bring in various China-based manufacturing partners to help round out the EV offerings under the Treeletrik brand.…

Continue Reading

FridayMar 13, 2020 12:26 pm

NetworkNewsBreaks – Akebia Therapeutics, Inc. (NASDAQ: AKBA) Featured in Mizuho Securities Research Report

Akebia Therapeutics, Inc. (NASDAQ: AKBA) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Akebia reported FY19 earnings yesterday. 4Q19 EPS was $(0.79) vs. Factset Consensus of $(0.47), and FY19 EPS was $(2.36) vs. FactSet Consensus of $(2.07). We do not see earnings as the most important value driver for Akebia at this stage. Importantly, the company remains on track to report Phase 3 data from vadadustat in 2Q20, and mid-2020. We expect investors will pay close attention to the data, including safety and efficacy compared to standard of care. We believe…

Continue Reading

FridayMar 13, 2020 12:18 pm

NetworkNewsBreaks – Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) Featured in Mizuho Securities Research Report

Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Satsuma reported better-than expected 4Q19 EPS loss of ($0.62) vs our ($0.79), driven by lower OpEx of $11M vs our $15M. However, we believe earnings numbers are not meaningful at this stage of its development. We continue to like STSA, believing STS101 remains underappreciated, and we like its strong cash position exiting 2019 that should take it to the end of 2021, which should shield it from needing to find additional funding in a potentially worsening capital markets…

Continue Reading

FridayMar 13, 2020 12:10 pm

NetworkNewsBreaks – Sage Therapeutics, Inc. (NASDAQ: SAGE) Featured in Mizuho Securities Research Report

Sage Therapeutics, Inc. (NASDAQ: SAGE) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Sage Therapeutics remains a controversial stock, with investors debating the regulatory path for zuranolone (SAGE-217). We continue to assume a 2023 launch in major depressive disorder as we expect Sage to do more dosing work and conduct at least one new Phase 3 trial. We present here proprietary analyses that further illustrate our view that differences seen with the 30mg dose in Phase 2 and Phase 3 were not simply due to chance, even if we exclude non-compliant…

Continue Reading

FridayMar 13, 2020 11:59 am

NetworkNewsBreaks – Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) Featured in Mizuho Securities Research Report

Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Xeris reported 4Q19 earnings yesterday. 4Q19 EPS of $(1.23) was below FactSet consensus of $(1.13). Revenue of $1.9 mil beat our estimate of $0.8 mil. In our opinion, revenue and revenue growth trajectory are likely the dominant metrics that investors judge Xeris by during 2020. The company launched the Gvoke pre-filled syringe (PFS) during 4Q19. Early product feedback from doctors has been positive, which matches the responses on our proprietary doctor calls. Furthermore, the commercial launch of the…

Continue Reading

FridayMar 13, 2020 11:48 am

NetworkNewsBreaks – Flower One Holdings, Inc. (CSE: FONE) (OTCQX: FLOOF) Featured in ROTH Equity Research Report

Flower One Holdings, Inc. (CSE: FONE) (OTCQX: FLOOF) was featured in a recent equity research report published by ROTH Capital Partners LLC. The report reads, “FONE pre-announced 4Q19 revenues of $5.7M vs our $5.0M estimate, leading to FY19 revenues of $9.4M. The company reported several key brand partnerships on the quarter including Heavy Hitters, The Clear and Cookies which we believe will drive continued market share growth in NV. FONE guided revenues in the $8-10M range for 1Q20 due to a slower-than-expected integration of new brand strains into its core portfolio, but we remain confident in the company's long-term trajectory.…

Continue Reading

FridayMar 13, 2020 11:44 am

NetworkNewsBreaks – Ideanomics’ (NASDAQ: IDEX) MEG Secures New Vehicle Order from Zhitong 3000

Ideanomics (NASDAQ: IDEX) on Thursday announced a new vehicle order through its MEG subsidiary from truck services firm Zhitong 3000's holding company Jiangsu Linghao Network Technology Co., Ltd. Per the update, the total order is in the region of 1.8 Billion Renminbi, or $250 Million USD, and is comprised of three order types. These include 3000 units of heavy haulage transportation vehicles at a cost of 400,000 Renminbi (approx. $57,000 USD), 1000 units of heavy dump trucks for use with transportation of slag and mining ore at a cost of 420,000 Renminbi (approx. $60,000 USD), as well as 800 passenger-class…

Continue Reading